台康生技股份有限公司

Welcome to EirGenix!  We are a $1B CDMO that specializes in biologic manufacturing and development. We have all the regulatory approvals (USFDA, EMA, TGA, PMDA), impeccable state-of-the-art facilities, product approval (with Sandoz), impeccable track record of excellence, great pricing, global reach, and an amazing team of seasoned experts. Speak with us to learn more about how we can make you and your biologic more successful! #biologics #biopharmaceuticals #biopharma #cdmo #biotech #biotechnology #biosimilars

World ADC is less than 2 weeks away in San Diego, CA. Visit EirGenix's booth #113 to discuss how we can support your complex ADC project. #EirGenix #WorldADC #CDMO #ADC #biosimilars

We’re excited to announce our participation at the World ADC Conference between November 4-7 in San Diego! Visit us at Booth #113 to discuss how EirGenix can be your partner and how we can support your ADC pipelines. Reach out if you’d like to schedule a meeting or chat during the event to peterlee@eirgenix.com for further information. #EirGenix #WorldADC #Biotech #CDMO #ADC #networking #biosimilars

⚾️⚾️⚾️⚾️⚾️ “The bases are loaded, and we’re ready to make a move. Are you prepared to hit a grand slam in your biologics development? Join us at BioJapan 2024 in Yokohama, Booth D-36, and discover how EirGenix, your trusted CDMO, can help you knock it out of the park. Let’s turn your project into a home run together!”💪💪💪💪💪💪 Oct 9~Oct 11, 2024 It’s the time now!! #EirGenix #CDMO #ADC #Biologics #BioJapan2024

🌐 Strengthening Taiwan’s Biopharmaceutical Position Globally 🌐 At EirGenix, we are proud to contribute to Taiwan’s growing presence in the global biopharmaceutical landscape through our comprehensive CDMO services. With end-to-end solutions, ranging from drug development to commercial manufacturing, EirGenix is dedicated to accelerating innovation and delivering high-quality, cost-effective treatments to patients worldwide. Our advanced facilities, talented teams, and commitment to excellence are driving new partnerships and breakthroughs in biologics, helping companies navigate the complexities of drug development. By leveraging Taiwan’s strategic advantages, we are creating value for our clients and pushing the boundaries of biopharmaceutical science. #EirGenix #Biopharma #CDMO #TaiwanBiopharma #GlobalHealthcare #DrugDevelopment #Innovation #Biologics

🌐 Strengthening Taiwan’s Biopharmaceutical Position Globally 🌐 At EirGenix, we are proud to contribute to Taiwan’s growing presence in the global biopharmaceutical landscape through our comprehensive CDMO services. With end-to-end solutions, ranging from drug development to commercial manufacturing, EirGenix is dedicated to accelerating innovation and delivering high-quality, cost-effective treatments to patients worldwide. Our advanced facilities, talented teams, and commitment to excellence are driving new partnerships and breakthroughs in biologics, helping companies navigate the complexities of drug development. By leveraging Taiwan’s strategic advantages, we are creating value for our clients and pushing the boundaries of biopharmaceutical science. #EirGenix #Biopharma #CDMO #TaiwanBiopharma #GlobalHealthcare #DrugDevelopment #Innovation #Biologics

🎉 Hey friends! We’re thrilled to share that EirGenix is heading to BioJapan 2024! Catch us at booth D-36 from October 9-11 in Yokohama. Let’s reconnect, chat about your latest projects, and explore how our CDMO services can help you reach the next level! See you there! 🙌 #BioJapan2024 #CDMO #EirGenix #Biomanufacturing

Hope to see you here！

Are you developing bispecific or poly-specific monoclonal antibodies (mAbs)? EirGenix’s latest blog post, “Key Considerations in Developing Bispecific mAbs,” delves into the critical factors you need to consider. This insightful article highlights key issues and features a case study where EirGenix successfully navigated significant challenges. The case study showcases the blend of precision, efficiency, and excellence in therapeutic protein development. Explore this article and many more on EirGenix’s Knowledge Platform (https://lnkd.in/gngj63j2). If you find the content valuable, please subscribe and help us spread the word! #CDMO #CLD #mAb #ADC #CMO #BispecificmAb #mAb #monoclonal https://lnkd.in/gVYFJpkG

Please reach out to me if you want a free pass to BPI. I'll be there to discuss your biologic project.